TAKEDA-L299-016

Study Sponsor : Takeda

Study Title

Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study to Determine the Safety, Pharmacokinetics, and Effectiveness of LDP-02 in Patients With Mildly to Moderately Active Crohn's Disease

Medicine or Vaccine (generic name)

vedolizumab

Sponsor Identification Number

L299-016

Trial Registry Identification Number(#'s)

NCT00655135

Medical Condition

Ulcerative Colitis; Crohn's Disease

Phase

Phase 2

Link to study details on the Takeda Clinical Study Register

http://takedaclinicaltrials.com/browse/summary/L299-016

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/show/NCT00655135

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

October 2014